Page 2 - E Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India Business News: Biological E's Covid-19 vaccine CORBEVAX has received emergency use listing from the World Health Organisation (WHO). The vaccine was approved in India for restricted use in emergency for adults, adolescents, and young children, as well as a heterologous booster dose for those aged 18 years and above. The Hyderabad-based vaccine maker has already supplied 100 million doses of CORBEVAX to the Indian government. The WHO EUL will help the company continue developing Covid-19 vaccines.

The dengue vaccine industry is on a promising growth trajectory, with an estimated valuation of US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is set to surge, with a projected sales volume CAGR of 12.9%.Dengue vaccine development has reached a pivotal phase in its lifecycle, marked by several pha...

/PRNewswire/ -- The paracetamol market size is set to grow by USD 791.9 million from 2022 to 2027 and register a CAGR of 8.78%, according to Technavio's latest...

According to a Future Market Insights (FMI) report, The Dengue Vaccines Market will expand positively, with a total valuation of US$ 474.8 million expected in 2023. The demand for dengue vaccinations is likely to increase at a CAGR of 12.9% by volume (units).Geographic OverviewLatin America is expected to remain the...

World is a better place when men and women are equal: Dr Sangeeta Reddy, Past President of FICCIG-20 Empower aims for 10 million registrations for its two platforms Mentorship and TechEquity